MX2022004549A - Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas. - Google Patents

Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas.

Info

Publication number
MX2022004549A
MX2022004549A MX2022004549A MX2022004549A MX2022004549A MX 2022004549 A MX2022004549 A MX 2022004549A MX 2022004549 A MX2022004549 A MX 2022004549A MX 2022004549 A MX2022004549 A MX 2022004549A MX 2022004549 A MX2022004549 A MX 2022004549A
Authority
MX
Mexico
Prior art keywords
variants
methods
making
cas12a
nucleases
Prior art date
Application number
MX2022004549A
Other languages
English (en)
Spanish (es)
Inventor
Joseph Matthew Watts
Sathya Sheela Jali
Original Assignee
Pairwise Plants Services Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pairwise Plants Services Inc filed Critical Pairwise Plants Services Inc
Publication of MX2022004549A publication Critical patent/MX2022004549A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04004Adenosine deaminase (3.5.4.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04005Cytidine deaminase (3.5.4.5)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
MX2022004549A 2019-10-17 2020-10-15 Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas. MX2022004549A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962916392P 2019-10-17 2019-10-17
PCT/US2020/055659 WO2021076682A1 (en) 2019-10-17 2020-10-15 Variants of cas12a nucleases and methods of making and use thereof

Publications (1)

Publication Number Publication Date
MX2022004549A true MX2022004549A (es) 2022-07-21

Family

ID=75492833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004549A MX2022004549A (es) 2019-10-17 2020-10-15 Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas.

Country Status (12)

Country Link
US (3) US11866745B2 (https=)
EP (1) EP4045643A4 (https=)
JP (2) JP7644755B2 (https=)
KR (1) KR20220097408A (https=)
CN (1) CN114829595A (https=)
AU (1) AU2020366358A1 (https=)
BR (1) BR112022007125A2 (https=)
CA (1) CA3157707A1 (https=)
CL (4) CL2022000937A1 (https=)
IL (1) IL292117A (https=)
MX (1) MX2022004549A (https=)
WO (1) WO2021076682A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
GB201506509D0 (en) 2015-04-16 2015-06-03 Univ Wageningen Nuclease-mediated genome editing
CN110382692A (zh) * 2016-04-19 2019-10-25 博德研究所 新型crispr酶以及系统
WO2018022634A1 (en) 2016-07-26 2018-02-01 The General Hospital Corporation Variants of crispr from prevotella and francisella 1 (cpf1)
WO2022174108A1 (en) * 2021-02-12 2022-08-18 The Board Of Trustees Of The Leland Stanford Junior University Synthetic cas12a for enhanced multiplex gene control and editing
CN113136376B (zh) * 2021-05-26 2022-10-21 武汉大学 一种Cas12a变体及其在基因编辑中的应用
CA3230609A1 (en) * 2021-09-08 2023-03-16 Shaorong Chong Compositions comprising a crispr nuclease and uses thereof
CN114214348A (zh) * 2021-11-16 2022-03-22 河南农业大学 应用于核酸检测的Crispr/LbCas12a突变体蛋白及其制备方法和应用
CN118339285A (zh) * 2021-12-09 2024-07-12 北京干细胞与再生医学研究院 工程化Cas12b效应子蛋白及其使用方法
IL314074A (en) * 2022-01-06 2024-09-01 Ensoma Aps CAS12A endonuclease variants and methods of use
EP4508205A1 (en) * 2022-04-12 2025-02-19 John Innes Centre Compositions and methods for increasing genome editing efficiency
AR129505A1 (es) * 2022-06-01 2024-09-04 Inst Genetics & Developmental Biology Cas Novedoso sistema de edición de genes crispr
CN116286734B (zh) * 2022-11-29 2024-04-02 武汉大学 野生型LbCas12a蛋白的突变体及SNP检测用途
CN116144631B (zh) * 2023-01-17 2023-09-15 华中农业大学 耐热型核酸内切酶及其介导的基因编辑系统
WO2024182746A1 (en) 2023-03-01 2024-09-06 Pairwise Plants Services, Inc. Engineered proteins and methods of use thereof
CN116410955B (zh) * 2023-03-10 2023-12-19 华中农业大学 两种新型核酸内切酶及其在核酸检测中的应用
CN116179512B (zh) * 2023-03-16 2023-09-15 华中农业大学 靶标识别范围广的核酸内切酶及其应用
WO2025007140A2 (en) 2023-06-30 2025-01-02 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
KR102789465B1 (ko) 2023-09-20 2025-04-04 주식회사 엔세이지 신규 CRISPR/Cas12a 시스템 및 그 유전자 편집 용도
CN119432813A (zh) * 2023-12-29 2025-02-14 武汉艾迪晶生物科技有限公司 Cas蛋白、组合蛋白、核酸分子、核糖核蛋白复合物、重组载体、转基因细胞及其应用
CN117844782B (zh) * 2024-03-06 2024-05-31 崖州湾国家实验室 靶向范围广的基因编辑核酸酶及其在核酸检测中的应用
US20250319206A1 (en) 2024-04-04 2025-10-16 Christina Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes
WO2025244732A1 (en) * 2024-05-24 2025-11-27 The Regents Of The University Of California Variant cas12a protein compositions and methods
US20260009010A1 (en) 2024-07-08 2026-01-08 Pairwise Plants Services, Inc. Methods and compositions for modification of protospacer adjacent motif specificity of cas12a
US12428636B1 (en) 2024-07-08 2025-09-30 Pairwise Plants Services, Inc. Methods and compositions for modification of protospacer adjacent motif specificity of CAS12A
CN119506250B (zh) * 2024-11-29 2025-09-09 大连理工大学 一种多PAM选择的基因编辑系统NovaCas-2及其应用
CN119876148B (zh) * 2025-01-23 2025-10-17 中国科学技术大学 Crispr rna突变体及其在基因编辑和核酸检测中的应用
CN121653102A (zh) * 2026-02-09 2026-03-13 武汉艾迪晶生物科技有限公司 一种Cas酶突变体及组合蛋白、核酸分子、重组载体、转基因细胞及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2017106657A1 (en) * 2015-12-18 2017-06-22 The Broad Institute Inc. Novel crispr enzymes and systems
WO2017127807A1 (en) * 2016-01-22 2017-07-27 The Broad Institute Inc. Crystal structure of crispr cpf1
CN110382692A (zh) 2016-04-19 2019-10-25 博德研究所 新型crispr酶以及系统
CN117925730A (zh) * 2016-04-21 2024-04-26 国立大学法人神户大学 提高基因组序列修饰技术中的突变导入效率的方法、及其使用的分子复合体
CA3038960A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Rna-guided nucleic acid modifying enzymes and methods of use thereof
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018195545A2 (en) * 2017-04-21 2018-10-25 The General Hospital Corporation Variants of cpf1 (cas12a) with altered pam specificity
EP3625342B1 (en) 2017-05-18 2022-08-24 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
WO2018213708A1 (en) 2017-05-18 2018-11-22 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
JP2019016859A (ja) 2017-07-04 2019-01-31 オリンパス株式会社 観察装置および観察方法
CN109957569B (zh) * 2017-12-22 2022-10-25 苏州齐禾生科生物科技有限公司 基于cpf1蛋白的碱基编辑系统和方法
BR112020014017A2 (pt) 2018-01-11 2020-12-08 KWS SAAT SE & Co. KGaA Sistemas crispr / cpf1 de plantas otimizados
CN108486146B (zh) * 2018-03-16 2021-02-19 中国农业科学院作物科学研究所 LbCpf1-RR突变体用于CRISPR/Cpf1系统在植物基因编辑中的应用

Also Published As

Publication number Publication date
US20240076639A1 (en) 2024-03-07
WO2021076682A1 (en) 2021-04-22
CL2024001737A1 (es) 2024-11-15
US20240076640A1 (en) 2024-03-07
CN114829595A (zh) 2022-07-29
IL292117A (en) 2022-06-01
JP7644755B2 (ja) 2025-03-12
AU2020366358A1 (en) 2022-04-28
JP2025087754A (ja) 2025-06-10
CL2024001734A1 (es) 2024-11-15
US11866745B2 (en) 2024-01-09
KR20220097408A (ko) 2022-07-07
NZ787124A (en) 2025-09-26
BR112022007125A2 (pt) 2022-07-05
US20210115421A1 (en) 2021-04-22
EP4045643A1 (en) 2022-08-24
CA3157707A1 (en) 2021-04-22
JP2022552409A (ja) 2022-12-15
CL2022000937A1 (es) 2023-01-20
EP4045643A4 (en) 2023-11-08
CL2024001733A1 (es) 2024-11-15

Similar Documents

Publication Publication Date Title
MX2022004549A (es) Variantes de nucleasas cas12a, metodos de fabricacion y uso de las mismas.
MX2019014640A (es) Nucleasas de repeticiones palíndromicas agrupadas y regularmente interespaciadas de proteina asociada 9 (cas9) genomanipuladas.
CO2019002252A2 (es) Variantes de alfa-glucosidasa ácida y usos de las mismas
IL271547A (en) T7 rna polymerase variants
IL271553A (en) T7 rna polymerase variants
CO2019002248A2 (es) Variantes de alfa-glucosidasa ácida y usos de las mismas
CO2018006667A2 (es) Moléculas de anticuerpo multiespecífico que tienen especificidad para tnf-alfa, il-17a e il-17f
MX2022006507A (es) Composiciones de acido ribonucleico de interferencia (arni) de angiopoyetina-tipo 3 (angptl3) y metodo de uso de las mismas.
EP3596098A4 (en) DNA AMPLIFICATION PROCESSES TO MAINTAIN A METHYLATION STATE
SI3719148T1 (sl) Izdelek iz jekla visoke trdote in način njegove izdelave
MX2019002606A (es) Formulaciones de (r)-2-amino-3-fenilpropil carbamato.
BR112018067408A2 (pt) formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
CR11152A (es) Metodos y composiciones para el tratamiento de enfermedades alergicas
MX2020005567A (es) Metodos de tratamiento con asparaginasa.
EP3934632A4 (en) Esketamine for the treatment of depression
MX2018007390A (es) Composiciones que comprenden acido 15-hidroxi eicosapentaenoico (15-hepe) y metodos de uso del mismo.
MX2018009794A (es) Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
EA201792610A1 (ru) Способ лечения неврологического заболевания
EP3778886A4 (en) Method for producing hairpin single-stranded rna molecule
EA202091259A1 (ru) Способ получения опикапона и его интермедиатов
EP3670661A4 (en) MYCOSPORIN-LIKE AMINO ACID PRODUCING MICRO-ORGANISM AND METHOD FOR MANUFACTURING MYCOSPORIN-LIKE AMINO ACID USING THESE
MX2021008819A (es) Analogos de cisteamina resistentes a la ado y sus usos.
IL261516A (en) Methods and compositions for increased double stranded rna production
EP3632890A4 (en) PROCESS FOR THE PRODUCTION OF ACID (METH) ACRYLIC
EP3571299A4 (en) RIBOSOMIC RNA ORIGAMI AND ITS PREPARATION PROCESSES